Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02018861 |
|---|---|
| Brief Title: | A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) |
| First Submitted : | December 5, 2013 |
| First Submitted that Met QC Criteria : | December 17, 2013 |
| First Posted : | December 23, 2013 (Estimate) |
| Results First Submitted : | April 7, 2022 |
| Results First Submitted that Met QC Criteria : | June 1, 2022 |
| Results First Posted : | June 28, 2022 |
| Last Update Submitted that Met QC Criteria : | June 1, 2022 |
| Last Update Posted : | June 28, 2022 |